Table 3 DSC thermal analysis (n = 3, mean ± standard deviation).

From: Design and development of innovative microparticulate/nanoparticulate inhalable dry powders of a novel synthetic trifluorinated chalcone derivative and Nrf2 agonist

Powder composition (molar ratio)

Spray drying pump rate (%)

Tpeak (°C)

ΔH (W/g)

Raw TMC

N/A

58.15 ± 0.38

90.65 ± 7.37

Co-SD TMC:Man 25:75

25

57.9 ± 0.01

21.79 ± 0.09

164.71 ± 0.31

186.93 ± 2.02

Co-SD TMC:Man 25:75

75

57.65 ± 0.03

26.41 ± 2.43

164.62 ± 0.18

185.37 ± 12.68

Co-SD TMC:Man 25:75

100

57.42 ± 0.06

20.18 ± 3.00

164.52 ± 0.02

156.97 ± 19.85

Back to article page